Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the effects of CO2 inhalation and acetazolamide treatment on exercise-induced
periodic breathing in patients with chronic stable heart failure.
Patients will be given CO2 (2%) during a constant workload exercise. Patients will be also
evaluated by maximal cardiopulmonary exercise test without and with acetazolamide acute and
chronic treatment.